EWT vs IBB
iShares MSCI Taiwan ETF vs iShares Biotechnology ETF
- • IBB has the lower expense ratio at 0.44% vs 0.59% for EWT.
- • EWT pays a higher dividend yield (0.92%).
Side-by-side metrics
| Metric | EWT | IBB |
|---|---|---|
Expense ratio Annual fee. Lower is better. | 0.59% | 0.44% |
Dividend yield Trailing 12-month yield. | 0.92% | 0.22% |
AUM Assets under management — bigger funds are typically more liquid. | $11.15B | $9.09B |
YTD return | 63.54% | 16.44% |
1-year return | — | — |
3-year return Annualized. | — | — |
5-year return Annualized. | — | — |
10-year return Annualized. | — | — |
Beta (3Y) Volatility relative to the market. Closer to 1 = market-like. | 1.24 | 0.69 |
P/E ratio | 29.38 | 24.79 |
Last price | $105.51 | $196.62 |
Inception | — | — |
Issuer | iShares | iShares |
EWT top holdings
| 2330.TW | Taiwan Semiconductor Manufacturing Co Ltd | 20.74% |
| 2454.TW | MediaTek Inc | 6.62% |
| 2308.TW | Delta Electronics Inc | 4.26% |
| 2317.TW | Hon Hai Precision Industry Co Ltd | 3.39% |
| 2327.TW | Yageo Corp | 3.20% |
| 3711.TW | ASE Technology Holding Co Ltd | 3.08% |
| 2303.TW | United Microelectronics Corp | 2.50% |
| 3037.TW | Unimicron Technology Corp | 2.39% |
| 2383.TW | Elite Material Co Ltd | 2.38% |
| 2345.TW | Accton Technology Corp | 2.01% |
IBB top holdings
| VRTX | Vertex Pharmaceuticals Inc | 8.07% |
| AMGN | Amgen Inc | 7.82% |
| GILD | Gilead Sciences Inc | 6.83% |
| REGN | Regeneron Pharmaceuticals Inc | 4.90% |
| ARGX | argenx SE ADR | 3.75% |
| ALNY | Alnylam Pharmaceuticals Inc | 3.12% |
| NTRA | Natera Inc | 2.89% |
| RVMD | Revolution Medicines Inc Ordinary Shares | 2.78% |
| BIIB | Biogen Inc | 2.46% |
| ILMN | Illumina Inc | 2.07% |
About EWT
EWT (iShares MSCI Taiwan ETF) is Taiwanese large- and mid-cap equities. Managed by iShares, the fund carries $11.2B in assets under management, an expense ratio of 0.59%, a dividend yield of 0.92%. Its largest holding is Taiwan Semiconductor Manufacturing Co Ltd (2330.TW), which represents 20.7% of the portfolio. Consumer Cyclical is the fund's largest sector exposure at 1.9%.
About IBB
IBB (iShares Biotechnology ETF) is NASDAQ biotech and pharmaceutical companies. Managed by iShares, the fund carries $9.1B in assets under management, an expense ratio of 0.44%, a dividend yield of 0.22%. Its largest holding is Vertex Pharmaceuticals Inc (VRTX), which represents 8.1% of the portfolio. Healthcare is the fund's largest sector exposure at 100.0%.